We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Marina Biotech Reports Interim Results of Their Phase 2-Enabling Toxicology Study for CEQ508

News   Feb 25, 2011

 
Marina Biotech Reports Interim Results of Their Phase 2-Enabling Toxicology Study for CEQ508
 
 
 

RELATED ARTICLES

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

Further Calls for Diversity in Genomics Research

News

Broadening diversity among participants in human genomics research will maximize the potential of the field, say members of an international genomics consortium.

READ MORE

Viagra – The Little Blue Pill Could Reshape Bone Marrow Transplants

News

A study published today in the journal Stem Cell Reports suggests that a combination of two clinically approved drugs – Viagra and Plerixafor – efficiently and rapidly mobilizes blood stem cells from the bone marrow into the bloodstream in a mouse model. This combination therapy may offer a new approach for bone marrow transplants in humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE